Back

Thromboembolic prevention in adolescents and adults with Fontan circulation: Is ASS a therapeutical option in long-standing Fontan circulation?

28 August 2018 (14:30 - 14:45)
Organised by:
Congress Presentation Part of: Drug therapy in congenital heart disease - What are the options and the needs? Prevention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Assistant Professor Mechthild Westhoff-Bleck

Hannover Medical School, Hannover (Germany)

4 More presentations in this session

Presentation thumbnail
Thromboembolism and bleeding in adults with congenital heart disease using non-vitamin K antagonist oral anticoagulants for thromboembolic prevention: a prospective worldwide observational study
Miss H. Yang (Singapore, SG)
Abstract
Presentation thumbnail
Combination of fenestrated atrial septal occluder with targeted medical therapy in patients with secundum atrial septal defect and severe pulmonary arterial hypertension
Doctor C. Yan (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Drug therapy in adult congenital heart disease: the burden of polypharmacy
Ms O. Woudstra (Amsterdam, NL)
Abstract
Presentation thumbnail
Selective Heart Rate inhibition improves inadequate exercise response in Fontan Circulation
Mr B. Ruijsink (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Drug therapy in congenital heart disease - What are the options and the needs?

The Event

Event poster

ESC Congress 2018

28 August 2018 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017
2 September 2019
thumbnail
Congress Presentation
Total pulmonary resistance as assessed by non-invasive pressure-flow plots is related to exercise capacity in Fontan patients
27 August 2023
thumbnail
Congress Session
Congenital heart disease throughout life
23 June 2023
thumbnail
Congress Presentation
Contemporary outcomes of catheter ablation for adult Fontan patients using advanced technologies
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources